AIMx partners with forward-thinking podiatrists to deliver Cash-pay solutions that expand what you can offer and grow your practice.
Most podiatrists are still limited to conventional treatments for complex conditions including chronic pain, fat pad atrophy, slow-healing tissue, and post-surgical recovery. AIMx exists to change that. We bring you a focused portfolio of regenerative cash-pay solutions that are clinically sound, compliantly positioned, and proven to move the needle for your practice and your patients.
From advanced biologics to practical clinical solutions, AIMx Podiatry delivers what today’s podiatrist needs to treat confidently, grow sustainably, and lead with innovation.
Address the painful effects of fat pad atrophy with Liposana®. This innovative, minimally invasive solution helps you provide lasting relief by restoring essential cushioning to your patients' feet. It's a highly sought-after, patient-funded treatment that enhances comfort and mobility, setting your practice apart.
DPMx is derived from umbilical cord structural tissue, which is naturally composed of extracellular matrix components such as collagen, elastin, and hyaluronan. The natural properties of this tissue may provide structural support and contribute to maintaining integrity, flexibility, and cushioning in areas of use.
Go beyond conventional approaches. Our physician-dispensed oral peptides are designed to work with the body’s natural processes, giving providers flexible options to incorporate into a wide range of patient care protocols.
From advanced biologics to practical clinical solutions, AIMx Podiatry delivers what today’s podiatrist needs to treat confidently, grow sustainably, and lead with innovation.
Working with AIMx has been a defining part of how I’ve built and delivered regenerative care in my practice. Their mission is clear and focused, advancing podiatry specifically rather than trying to be everything to everyone, and that level of specialization shows in the education, resources, and support they provide to physicians. They don’t just supply products, they partner with doctors to elevate standards and ensure we practice with intention and integrity. Their commitment to ethical sourcing, transparency, and regulatory responsibility is unmatched, which is why I trust them without hesitation. When it comes to regenerative medicine in podiatry, AIMx is the standard I rely on for both quality and principle.
AIMx Podiatry has been an outstanding company to work with. Their customer service is consistently exceptional, and—most importantly—their products deliver real results. AIM has introduced some of the most meaningful innovations in podiatry, and they’ve truly become a onestop shop for regenerative medicine. Their solutions make a measurable difference in patient outcomes and practice efficiency, and partnering with them has been nothing short of phenomenal.
I have been practicing regenerative medicine for over 15 years and have used a wide range of products. AIMx Podiatry stands out for delivering high-quality solutions that produce effective results in a shorter time frame compared to many alternatives.
When used with the appropriate diagnosis and treatment protocols, I consistently see high patient satisfaction and strong clinical outcomes. Their regenerative portfolio—including peptide therapy, umbilical cord allograft and fat pad restoration—has become a key part of my practice.
In addition, their team is knowledgeable, responsive, and committed to both physician and patient success. AIMx is a trusted partner in delivering advanced regenerative care.
To say this product has greatly helped my patients would be an understatement. The number of surgeries that I am doing has been drastically reduced simply because patients have been getting better and not needing surgery at all.
I’ve been using AIMx products for a year, and DPMx and Liposana have become staples in my treatment protocols with consistently impressive outcomes. The quality of their products and the level of support from their team are second to none
© 2026 AIMx Podiatry. All rights reserved.